JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Home
Search results for: 'research area pi3k akt signaling gsk'

Search results for: 'research area pi3k akt signaling gsk'

A8169 Everolimus (RAD001)

8 Citation

Target: mTOR

Summary: MTOR inhibitor

≥47.91 mg/mL
A8214 AZD8055

2 Citation

Target: mTOR

Summary: MTOR inhibitor

≥23.3 mg/mL
A8346 BYL-719

1 Citation

Target: PI3K

Summary: Selective PI3Kα inhibitor

≥22.07 mg/mL
A3010 MK-2206 dihydrochloride

21 Citation

Target: Akt

Summary: Akt1/2/3 inhibitor

insoluble in EtOH; ≥12.01 mg/mL
A3446 GSK126

5 Citation

Target: EZH2

Summary: EZH2 inhibitor

insoluble in H2O; insoluble in EtOH; ≥4.38 mg/mL
A3133 A 83-01

Summary: ALK-5 inhibitor

≥21.1 mg/mL
B3686 DMH-1

Target: BMP and Other Activin Receptors

Summary: Selective BMP ALK2 receptor

insoluble in H2O; insoluble in EtOH; ≥9.51 mg/mL
B1642 WYE-125132 (WYE-132)

Target: mTOR

Summary: ATP-competitive mTOR inhibitor, highly potent

insoluble in EtOH; insoluble in H2O; ≥13 mg/mL